Literature DB >> 25262882

Impact of long-term cryopreservation on single umbilical cord blood transplantation outcomes.

Richard Mitchell1, John E Wagner1, Claudio G Brunstein2, Qing Cao3, David H McKenna4, Troy C Lund1, Michael R Verneris5.   

Abstract

Umbilical cord blood (UCB) may be collected and cryopreserved for years before use. In vitro and murine models suggest that the duration of storage does not affect UCB progenitor cell performance; however, the impact of UCB age on clinical outcomes has not been definitely defined. This study sought to determine the effect of UCB unit cryopreservation time on hematopoietic potency. We analyzed 288 single UCB units used for transplantation from 1992 to 2013, with unit cryopreservation time ranging from .08 to 11.07 years. UCB unit post-thaw characteristics were examined, including percent recovery of total nucleated cells (TNC). The number of years the UCB unit spent in cryopreservation had no impact on TNC recovery nor UCB unit post-thaw viability. Duration of cryopreservation also had no impact on neutrophil or platelet engraftment in single UCB transplantations. These results show that UCB units can undergo cryopreservation for at least 10 years with no impact on clinical outcomes.
Copyright © 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Neutrophil recovery; UCB storage time; UCB transplantation; Umbilical cord blood (UCB)

Mesh:

Year:  2014        PMID: 25262882      PMCID: PMC4378826          DOI: 10.1016/j.bbmt.2014.09.002

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  24 in total

1.  Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood.

Authors:  Hal E Broxmeyer; Man-Ryul Lee; Giao Hangoc; Scott Cooper; Nutan Prasain; Young-June Kim; Coleen Mallett; Zhaohui Ye; Scott Witting; Kenneth Cornetta; Linzhao Cheng; Mervin C Yoder
Journal:  Blood       Date:  2011-03-10       Impact factor: 22.113

2.  Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood.

Authors:  Claudio G Brunstein; Jonathan A Gutman; Daniel J Weisdorf; Ann E Woolfrey; Todd E Defor; Theodore A Gooley; Michael R Verneris; Frederick R Appelbaum; John E Wagner; Colleen Delaney
Journal:  Blood       Date:  2010-08-04       Impact factor: 22.113

3.  Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies.

Authors:  Juliet N Barker; Andromachi Scaradavou; Cladd E Stevens
Journal:  Blood       Date:  2009-12-22       Impact factor: 22.113

4.  Is there an expiration date for a cord blood unit in storage?

Authors:  S Parmar; M de Lima; L Worth; D Petropoulos; D Lee; L Cooper; P Kongtim; A Alousi; C Hosing; U Popat; P Kebriaei; I McNiece; E Shpall; G Rondon; R Champlin
Journal:  Bone Marrow Transplant       Date:  2014-04-23       Impact factor: 5.483

5.  Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities.

Authors:  Juliet N Barker; Courtney E Byam; Nancy A Kernan; Sinda S Lee; Rebecca M Hawke; Kathleen A Doshi; Deborah S Wells; Glenn Heller; Esperanza B Papadopoulos; Andromachi Scaradavou; James W Young; Marcel R M van den Brink
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-25       Impact factor: 5.742

6.  HPC viability measurement: trypan blue versus acridine orange and propidium iodide.

Authors:  K Mascotti; J McCullough; S R Burger
Journal:  Transfusion       Date:  2000-06       Impact factor: 3.157

7.  Costs of pediatric allogeneic hematopoietic-cell transplantation.

Authors:  Navneet S Majhail; Jaya M Mothukuri; Margaret L Macmillan; Michael R Verneris; Paul J Orchard; John E Wagner; Daniel J Weisdorf
Journal:  Pediatr Blood Cancer       Date:  2010-01       Impact factor: 3.167

8.  High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years.

Authors:  Hal E Broxmeyer; Edward F Srour; Giao Hangoc; Scott Cooper; Stacie A Anderson; David M Bodine
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-07       Impact factor: 11.205

9.  Real-world costs of autologous and allogeneic stem cell transplantations for haematological diseases: a multicentre study.

Authors:  H M Blommestein; S G R Verelst; P C Huijgens; N M A Blijlevens; J J Cornelissen; C A Uyl-de Groot
Journal:  Ann Hematol       Date:  2012-08-05       Impact factor: 3.673

10.  Cost effectiveness of cord blood versus bone marrow and peripheral blood stem cells.

Authors:  Thomas Bart
Journal:  Clinicoecon Outcomes Res       Date:  2010-10-05
View more
  8 in total

1.  Impact of Delayed Infusion Time in Umbilical Cord Blood Transplantation.

Authors:  Richard Mitchell; John E Wagner; Claudio Brunstein; Qing Cao; David H McKenna; Michael R Verneris
Journal:  Biol Blood Marrow Transplant       Date:  2017-02-15       Impact factor: 5.742

2.  How old is too old? In vivo engraftment of human peripheral blood stem cells cryopreserved for up to 18 years - implications for clinical transplantation and stability programs.

Authors:  John Underwood; Mahvish Rahim; Carijo West; Rebecca Britton; Elaine Skipworth; Vicki Graves; Steven Sexton; Hillary Harris; Dave Schwering; Anthony Sinn; Karen E Pollok; Kent A Robertson; W Scott Goebel; Kerry M Hege
Journal:  World J Stem Cells       Date:  2020-05-26       Impact factor: 5.326

3.  Differentiated Cells Derived from Hematopoietic Stem Cells and Their Applications in Translational Medicine.

Authors:  Sophia S Fernandes; Lalita S Limaye; Vaijayanti P Kale
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Umbilical cord blood transplantation supplemented with the infusion of mesenchymal stem cell for an adolescent patient with severe aplastic anemia: a case report and review of literature.

Authors:  Chengxin Luan; Runzhe Chen; Baoan Chen; Jiahua Ding; Ming Ni
Journal:  Patient Prefer Adherence       Date:  2015-06-11       Impact factor: 2.711

5.  Effects of Cryopreservation Duration on the Outcome of Single-Unit Cord Blood Transplantation.

Authors:  Tang-Her Jaing; Shih-Hsiang Chen; Yu-Chuan Wen; Tsung-Yen Chang; Ya-Chun Yang; Pei-Kwei Tsay
Journal:  Cell Transplant       Date:  2018-05-08       Impact factor: 4.064

6.  High Integrity and Fidelity of Long-Term Cryopreserved Umbilical Cord Blood for Transplantation.

Authors:  Gee-Hye Kim; Jihye Kwak; Sung Hee Kim; Hee Jung Kim; Hye Kyung Hong; Hye Jin Jin; Soo Jin Choi; Wonil Oh; Soyoun Um
Journal:  J Clin Med       Date:  2021-01-14       Impact factor: 4.241

7.  Child with Wiskott-Aldrich syndrome underwent atypical immune reconstruction after umbilical cord blood transplantation: A case report.

Authors:  Bo-Han Li; Shao-Yan Hu
Journal:  World J Clin Cases       Date:  2019-11-06       Impact factor: 1.337

8.  Long-Term Cryopreservation Does Not Affect Quality of Peripheral Blood Stem Cell Grafts: A Comparative Study of Native, Short-Term and Long-Term Cryopreserved Haematopoietic Stem Cells.

Authors:  Daniel Lysak; Michaela Brychtová; Martin Leba; Miroslava Čedíková; Daniel Georgiev; Pavel Jindra; Tomáš Vlas; Monika Holubova
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.